Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 287–293
http://dx.doi.org/10.1155/2013/731609
Research Article

Association between Angiotensin II Type 1 Receptor Polymorphism and Sudden Cardiac Death in Myocardial Infarction

1Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilisation Diseases, Slovak Academy of Sciences, Sienkiewiczova 1, 813 71 Bratislava, Slovakia
2Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's Faculty Hospital and Masaryk University, Pekarska 53, 602 00 Brno, Czech Republic
35th Department of Internal Medicine, University Hospital and Medical Faculty, Comenius University, Ruzinovska 6, 826 06 Bratislava, Slovakia

Received 17 June 2013; Accepted 21 August 2013

Academic Editor: Grant Izmirlian

Copyright © 2013 Peter Kruzliak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Braunwald, Ed., Heart Disease: A Textbook of Cardiovascular Medicine, WB Saunders, Philadelphia, Pa, USA, 1997.
  2. E. Ambrosioni, S. Bacchelli, D. D. Esposti, and C. Borghi, “ACE-inhibitors and atherosclerosis,” European Journal of Epidemiology, vol. 8, no. 1, pp. 129–133, 1992. View at Google Scholar · View at Scopus
  3. T. W. Kurtz, “The ACE of hearts,” Nature, vol. 359, no. 6396, pp. 588–589, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. J. Singer, C. G. Missouris, and S. Jeffery, “Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion?” Circulation, vol. 94, no. 3, pp. 236–239, 1996. View at Google Scholar · View at Scopus
  5. M. M. Morales-Suárez-Varela, M. L. Mansego, A. M. Vicedo-Cabrera et al., “Inefficient arterial hypertension control in patients with metabolic syndrome and its link to renin-angiotensin-aldosterone system polymorphisms,” Hypertension Research, vol. 34, no. 6, pp. 758–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. I. A. Reid, “The renin-angiotensin system: physiology, pathophysiology, and pharmacology,” The American Journal of Physiology, vol. 275, no. 6, pp. S236–S245, 1998. View at Google Scholar · View at Scopus
  7. M. G. Nicholls, A. M. Richards, and M. Agarwal, “The importance of the renin-angiotensin system in cardiovascular disease,” Journal of Human Hypertension, vol. 12, no. 5, pp. 295–299, 1998. View at Google Scholar · View at Scopus
  8. A. Bonnardeaux, E. Davies, X. Jeunemaitre et al., “Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension,” Hypertension, vol. 24, no. 1, pp. 63–69, 1994. View at Google Scholar · View at Scopus
  9. A. T. Chiu, W. F. Herblin, D. E. McCall et al., “Identification of angiotensin II receptor subtypes,” Biochemical and Biophysical Research Communications, vol. 165, no. 1, pp. 196–203, 1989. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Ranjith, R. J. Pegoraro, L. Rom, P. A. Lanning, and D. P. Naidoo, “Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians,” Cardiovascular Journal of South Africa, vol. 15, no. 1, pp. 22–26, 2004. View at Google Scholar · View at Scopus
  11. M. A. de Araújo, B. S. Menezes, C. Lourenço, E. R. Cordeiro, R. Rispoli Gatti, and L. R. Goulart, “The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction,” Arquivos Brasileiros de Cardiologia, vol. 83, no. 5, pp. 404–408, 2004. View at Google Scholar · View at Scopus
  12. M. Buraczyńska, Z. Pijanowski, D. Spasiewicz et al., “Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease,” Kardiologia Polska, vol. 58, no. 1, pp. 1–9, 2003. View at Google Scholar · View at Scopus
  13. K. E. Berge, A. Bakken, M. Bøhn, J. Erikssen, and K. Berg, “A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction,” Clinical Genetics, vol. 52, no. 2, pp. 71–76, 1997. View at Google Scholar · View at Scopus
  14. L. Tiret, A. Bonnardeaux, O. Poirier et al., “Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction,” The Lancet, vol. 344, no. 8927, pp. 910–913, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. C. W. Hamm, J. P. Bassand, S. Agewall et al., “ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC),” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Google Scholar · View at Scopus
  16. P. G. Steg, S. K. James, D. Atar et al., “ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar
  17. G. Mancia, G. de Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano, “Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension and of the european society of cardiology,” Journal of Hypertension, vol. 25, pp. 1105–1187, 2007. View at Google Scholar · View at Scopus
  18. L. Rydén, E. Standl, B. Małgorzata et al., “Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the european society of cardiology (ESC) and of the european association for the study of diabetes (EASD),” European Heart Journal, vol. 28, no. 1, pp. 88–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Reiner, A. L. Catapano, G. de Backer et al., “ESC/EAS Guidelines for the management of dyslipidaemias. The task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS),” European Heart Journal, vol. 32, no. 4, pp. 1769–1818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. F. Guo, Y. L. Sun, P. Hamet, and T. Inagami, “The angiotensin II type 1 receptor and receptor-associated proteins,” Cell Research, vol. 11, no. 3, pp. 165–180, 2001. View at Google Scholar · View at Scopus
  21. W. C. Paxton, Ruglssi, C. Horulst et al., “Imunohistochemical localization of rat angiotensin II at 1 receptor,” The American Journal of Physiology, vol. 264, pp. 989–995, 1993. View at Google Scholar
  22. R. Ross, “Atherosclerosis: an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. N. Jiang, W. S. Zhao, F. Yu, and G. Xu, “Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension,” Chinese Medical Journal, vol. 114, no. 12, pp. 1249–1251, 2001. View at Google Scholar · View at Scopus
  24. Y. Tanaka, K. Tamura, Y. Koide et al., “The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy,” FEBS Letters, vol. 579, no. 7, pp. 1579–1586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yu, G. N. Prado, L. Taylor, R. Pal-Ghosh, and P. Polgar, “Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction,” International Immunopharmacology, vol. 2, no. 13-14, pp. 1807–1822, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Mizuno, M. Makino, Y. Fujiwara et al., “Renin-angiotensin system gene polymorphism in Japanese stroke patients,” International Congress Series, vol. 1252, pp. 83–90, 2003. View at Publisher · View at Google Scholar
  27. A. Jones, S. S. Dhamrait, J. R. Payne et al., “Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension,” Hypertension, vol. 42, no. 4, pp. 500–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Duncan, J. W. Scholey, and J. A. Miller, “Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes,” Current Opinion in Nephrology and Hypertension, vol. 10, no. 1, pp. 111–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Ulgen, O. Ozturk, M. Yazici et al., “Association between A/C1166 gene polymorphism of the angiotensin II type 1 receptor and biventricular functions in patients with acute myocardial infarction,” Circulation Journal, vol. 70, no. 10, pp. 1275–1279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Álvarez, J. R. Reguero, A. Batalla et al., “Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease,” Cardiovascular Research, vol. 40, no. 2, pp. 375–379, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Gardemann, Q. D. Nguyen, J. Humme et al., “Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism an the risk of these diseases,” European Heart Journal, vol. 19, no. 11, pp. 1657–1665, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. G. I. Rice, C. A. Foy, and P. J. Grant, “Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease,” Cardiovascular Research, vol. 41, no. 3, pp. 746–753, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. J. E. Eichner, V. J. Christiansen, W. E. Moore, S. T. Dunn, and E. Schechter, “Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients,” Atherosclerosis, vol. 154, no. 3, pp. 673–679, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Castellano, M. L. Muiesan, M. Beschi et al., “Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure,” Hypertension, vol. 28, no. 6, pp. 1076–1080, 1996. View at Google Scholar · View at Scopus